Biotech

All Articles

Exelixis goes down ADC after choosing it's no match for Tivdak

.Exelixis is losing hope on its cells aspect (TF)- targeting antibody-drug conjugate after wrapping ...

Relay loses interest in SHP2 inhibitor after Genentech leaves behind

.Three weeks after Roche's Genentech device walked away from an SHP2 prevention contract, Relay Reha...

Stoke's Dravet syndrome med launched of partial clinical grip

.Stoke Therapeutics' Dravet disorder drug has been actually without a partial hold, removing the tec...

Fierce Biotech's Gabrielle Masson offers Strong 15 at NYSE

.Tough Biotech Affiliate Editor Gabrielle Masson presented the 2024 course of Ferocious 15 winners o...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its own once-monthly twin GLP-1/ GIP receptor agonist, finishing (PD...

Daiichi spends Merck $170M to create bronchi cancer T-cell engager contract

.Merck &amp Co. has actually promptly redeemed a few of the prices of its own Weapon Therapeutics pu...

BioMarin halts preclinical genetics treatment for heart disease

.After BioMarin carried out a springtime tidy of its pipeline in April, the company has determined t...

Eisai plants molecular glue SEED along with $1.5 B biobucks work

.Major Pharmas stay caught to the idea of molecular glue degraders. The most up to date provider to ...

Life science credit report organization unveils with $600M

.A new worldwide life scientific research credit scores organization, referred to Symbiotic Funds, h...

BMS channels TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more huge bet coming from the Caforio age, canceling a p...